drugs with tirzepatide FDA approves new version of diabetes drug Mounjaro to be sold for weight loss Tirzepatide (Zepbound, Mounjaro): Weight Loss,

Clinical studies show patients can lose 10-15% of their body weight over 6-12 months

M.GuptaP

It fills critical gaps in the medical literature by supporting the medication's real-world effectiveness in older adults aged 75 and older and demonstrating positive effects on ALT, a liver enzyme marker

Mild and temporary reactions may occur in some cases

Its just been one surprise after the next, Habener said

That said, these effects are not yet well established clinically, and more research is needed to determine whether they are directly caused by the medication or influenced by factors such as weight loss, metabolic changes, or individual physiology